Bevacizumab + chemotherapy increases risk of arterial thromboembolic events

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2005年 / 1056卷 / 1期
关键词：
Public Health; Lung Cancer; Multivariate Analysis; Bevacizumab; Cell Lung Cancer;
D O I：
10.2165/00128415-200510560-00007
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [1] Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
    Scappaticci, Frank A.
    Skillings, Jamey R.
    Holden, Scott N.
    Gerber, Hans-Peter
    Miller, Kathy
    Kabbinavar, Fairooz
    Bergsland, Emily
    Ngai, James
    Holmgren, Eric
    Wang, Jiuzhou
    Hurwitz, Herbert
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (16) : 1232 - 1239
  • [2] Bevacizumab plus chemotherapy increases risk of arterial thromboembolism
    [J]. Nature Clinical Practice Oncology, 2007, 4 (12): : 678 - 678
  • [3] Arterial thromboembolic events in a pooled analysis of 5 randomized, controlled trials of bevacizumab with chemotherapy
    Skillings, J.
    Johnson, D.
    Miller, K.
    Kabbinavar, F.
    Bergsland, E.
    Holmgren, E.
    Holden, S. N.
    Hurwitz, H.
    Scappaticci, F.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 179 - 179
  • [4] Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
    Tebbutt, N. C.
    Murphy, F.
    Zannino, D.
    Wilson, K.
    Cummins, M. M.
    Abdi, E.
    Strickland, A. H.
    Lowenthal, R. M.
    Marx, G.
    Karapetis, C.
    Shannon, J.
    Goldstein, D.
    Nayagam, S. S.
    Blum, R.
    Chantrill, L.
    Simes, R. J.
    Price, T. J.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (08) : 1834 - 1838
  • [5] Chemotherapy plus bevacizumab for metastasizing carcinomas: The combination increases the risk of arterial thromboembolism
    Pilz, Lothar R.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (05) : 285 - 286
  • [6] Arterial thromboembolic events and patients with metastatic carcinoma treated with chemotherapy and bevacizumab (vol 99, pg 1232, 2007)
    不详
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (02) : 156 - 156
  • [7] Arterial thromboembolic events and patients with metastatic carcinoma treated with chemotherapy and bevacizumab (vol 99, pg 1232, 2007)
    Scappaticci, F. A.
    Skillings, J. R.
    Holden, S. N.
    Gerber, H. -P.
    Miller, K.
    Kabbinavar, F.
    Bergsland, E.
    Ngai, J.
    Holmgren, E.
    Wang, J.
    Hurwitz, H.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09)
  • [8] Thromboembolic events and bleeding in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
    Isabel Ferrer, Ana
    Luis Sanchez, Jose
    Carmen Rodriguez, Maria
    Soriano, Carmen
    Alberto Aliaga, Luis
    Garcia Nieto, Sandra
    Carmen Alonso, Maria
    Fernandez, Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] THROMBOEMBOLIC EVENTS ASSOCIATED WITH BEVACIZUMAB PLUS CHEMOTHERAPY FOR PATIENTS WITH OVARIAN CANCER
    Takasaki, K.
    Miyamoto, M.
    Takano, M.
    Soyama, H.
    Aoyama, T.
    Matsuura, H.
    Kato, K.
    Sakamoto, T.
    Oyaizu, M.
    Iwahashi, H.
    Ishibashi, H.
    Yoshikawa, T.
    Huruya, K.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 850 - 850
  • [10] Bevacizumab increases risk of arterial thromboembolism and MI
    [J]. Reactions Weekly, 2010, 1299 (1) : 3 - 3
12345